BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: De Rycker M, Baragaña B, Duce SL, Gilbert IH. Challenges and recent progress in drug discovery for tropical diseases. Nature 2018;559:498-506. [PMID: 30046073 DOI: 10.1038/s41586-018-0327-4] [Cited by in Crossref: 73] [Cited by in F6Publishing: 63] [Article Influence: 18.3] [Reference Citation Analysis]
Number Citing Articles
1 Yang G, Chen S, Zhang J. Bioinspired and Biomimetic Nanotherapies for the Treatment of Infectious Diseases. Front Pharmacol 2019;10:751. [PMID: 31333467 DOI: 10.3389/fphar.2019.00751] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 8.7] [Reference Citation Analysis]
2 Cianni L, Feldmann CW, Gilberg E, Gütschow M, Juliano L, Leitão A, Bajorath J, Montanari CA. Can Cysteine Protease Cross-Class Inhibitors Achieve Selectivity? J Med Chem 2019;62:10497-525. [DOI: 10.1021/acs.jmedchem.9b00683] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 7.7] [Reference Citation Analysis]
3 Liu ZQ. Bridging free radical chemistry with drug discovery: A promising way for finding novel drugs efficiently. Eur J Med Chem 2020;189:112020. [PMID: 32006794 DOI: 10.1016/j.ejmech.2019.112020] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
4 Liu KL, Teng F, Xiong L, Li X, Gao C, Yu LT. Discovery of quinolone derivatives as antimycobacterial agents. RSC Adv 2021;11:24095-115. [PMID: 35479020 DOI: 10.1039/d0ra09250a] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
5 Hai Y, Cai Z, Li P, Wei M, Wang C, Gu Y, Shao C. Trends of antimalarial marine natural products: progresses, challenges and opportunities. Nat Prod Rep . [DOI: 10.1039/d1np00075f] [Reference Citation Analysis]
6 Lopes EA, Mestre R, Fontinha D, Legac J, Pei JV, Sanches-vaz M, Mori M, Lehane AM, Rosenthal PJ, Prudêncio M, Santos MM. Discovery of spirooxadiazoline oxindoles with dual-stage antimalarial activity. European Journal of Medicinal Chemistry 2022. [DOI: 10.1016/j.ejmech.2022.114324] [Reference Citation Analysis]
7 Clare RH, Clark R, Bardelle C, Harper P, Collier M, Johnston KL, Plant H, Plant D, McCall E, Slatko BE, Cantin L, Wu B, Ford L, Murray D, Rich K, Wigglesworth M, Taylor MJ, Ward SA. Development of a High-Throughput Cytometric Screen to Identify Anti- Wolbachia Compounds: The Power of Public-Private Partnership. SLAS Discov 2019;24:537-47. [PMID: 30958712 DOI: 10.1177/2472555219838341] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Ghosh S, Farr L, Singh A, Leaton LA, Padalia J, Shirley DA, Sullivan D, Moonah S. COP9 signalosome is an essential and druggable parasite target that regulates protein degradation. PLoS Pathog 2020;16:e1008952. [PMID: 32960936 DOI: 10.1371/journal.ppat.1008952] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
9 Lin C, Hulpia F, da Silva CF, Batista DDGJ, Van Hecke K, Maes L, Caljon G, Soeiro MDNC, Van Calenbergh S. Discovery of Pyrrolo[2,3- b ]pyridine (1,7-Dideazapurine) Nucleoside Analogues as Anti- Trypanosoma cruzi Agents. J Med Chem 2019;62:8847-65. [DOI: 10.1021/acs.jmedchem.9b01275] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
10 Xie YP, Ansari MF, Zhang SL, Zhou CH. Novel carbazole-oxadiazoles as potential Staphylococcus aureus germicides. Pestic Biochem Physiol 2021;175:104849. [PMID: 33993967 DOI: 10.1016/j.pestbp.2021.104849] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
11 Bernal FA, Kaiser M, Wünsch B, Schmidt TJ. Structure-Activity Relationships of Cinnamate Ester Analogues as Potent Antiprotozoal Agents. ChemMedChem 2020;15:68-78. [PMID: 31697437 DOI: 10.1002/cmdc.201900544] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 5.7] [Reference Citation Analysis]
12 Thomas M, Brand S, De Rycker M, Zuccotto F, Lukac I, Dodd PG, Ko EJ, Manthri S, McGonagle K, Osuna-Cabello M, Riley J, Pont C, Simeons F, Stojanovski L, Thomas J, Thompson S, Viayna E, Fiandor JM, Martin J, Wyatt PG, Miles TJ, Read KD, Marco M, Gilbert IH. Scaffold-Hopping Strategy on a Series of Proteasome Inhibitors Led to a Preclinical Candidate for the Treatment of Visceral Leishmaniasis. J Med Chem 2021;64:5905-30. [PMID: 33904304 DOI: 10.1021/acs.jmedchem.1c00047] [Reference Citation Analysis]
13 Gupta R. Advancing new tools for infectious diseases. Science 2020;370:913-4. [PMID: 33214267 DOI: 10.1126/science.abe0773] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
14 Scalese G, Kostenkova K, Crans DC, Gambino D. Metallomics and other omics approaches in antiparasitic metal-based drug research. Current Opinion in Chemical Biology 2022;67:102127. [DOI: 10.1016/j.cbpa.2022.102127] [Reference Citation Analysis]
15 Hulpia F, Bouton J, Campagnaro GD, Alfayez IA, Mabille D, Maes L, de Koning HP, Caljon G, Van Calenbergh S. C6-O-alkylated 7-deazainosine nucleoside analogues: Discovery of potent and selective anti-sleeping sickness agents. Eur J Med Chem 2020;188:112018. [PMID: 31931339 DOI: 10.1016/j.ejmech.2019.112018] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
16 Novello CR, Düsman E, Balbinot RB, de Paula JC, Nakamura CV, de Mello JCP, Sarragiotto MH. Antileishmanial activity of neo -clerodane diterpenes from Croton echioides. Natural Product Research. [DOI: 10.1080/14786419.2020.1851221] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Kratz JM, Gonçalves KR, Romera LM, Moraes CB, Bittencourt-Cunha P, Schenkman S, Chatelain E, Sosa-Estani S. The translational challenge in Chagas disease drug development. Mem Inst Oswaldo Cruz 2022;117:e200501. [PMID: 35613156 DOI: 10.1590/0074-02760200501] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Torrie LS, Zuccotto F, Robinson DA, Gray DW, Gilbert IH, De Rycker M. Identification of inhibitors of an unconventional Trypanosoma brucei kinetochore kinase. PLoS One 2019;14:e0217828. [PMID: 31150492 DOI: 10.1371/journal.pone.0217828] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
19 Rink C, Ciganda M, Williams N. The Nuclear Export Receptors TbMex67 and TbMtr2 Are Required for Ribosome Biogenesis in Trypanosoma brucei. mSphere 2019;4:e00343-19. [PMID: 31270172 DOI: 10.1128/mSphere.00343-19] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
20 Bernal FA, Gerhards M, Kaiser M, Wünsch B, Schmidt TJ. (±)-trans-2-phenyl-2,3-dihydrobenzofurans as leishmanicidal agents: Synthesis, in vitro evaluation and SAR analysis. European Journal of Medicinal Chemistry 2020;205:112493. [DOI: 10.1016/j.ejmech.2020.112493] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
21 Kourbeli V, Chontzopoulou E, Moschovou K, Pavlos D, Mavromoustakos T, Papanastasiou IP. An Overview on Target-Based Drug Design against Kinetoplastid Protozoan Infections: Human African Trypanosomiasis, Chagas Disease and Leishmaniases. Molecules 2021;26:4629. [PMID: 34361781 DOI: 10.3390/molecules26154629] [Reference Citation Analysis]
22 Leeder WM, Giehler F, Joswig J, Göringer HU. Bioinspired Design of Lysolytic Triterpenoid-Peptide Conjugates that Kill African Trypanosomes. Chembiochem 2019;20:1251-5. [PMID: 30609206 DOI: 10.1002/cbic.201800674] [Reference Citation Analysis]
23 Shirley DA, Sharma I, Warren CA, Moonah S. Drug Repurposing of the Alcohol Abuse Medication Disulfiram as an Anti-Parasitic Agent. Front Cell Infect Microbiol 2021;11:633194. [PMID: 33777846 DOI: 10.3389/fcimb.2021.633194] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Hulpia F, Campagnaro GD, Alzahrani KJ, Alfayez IA, Ungogo MA, Mabille D, Maes L, de Koning HP, Caljon G, Van Calenbergh S. Structure-Activity Relationship Exploration of 3'-Deoxy-7-deazapurine Nucleoside Analogues as Anti-Trypanosoma brucei Agents. ACS Infect Dis 2020;6:2045-56. [PMID: 32568511 DOI: 10.1021/acsinfecdis.0c00105] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
25 Kratz JM. Drug discovery for chagas disease: A viewpoint. Acta Trop 2019;198:105107. [PMID: 31351074 DOI: 10.1016/j.actatropica.2019.105107] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 9.3] [Reference Citation Analysis]
26 Arendse LB, Wyllie S, Chibale K, Gilbert IH. Plasmodium Kinases as Potential Drug Targets for Malaria: Challenges and Opportunities. ACS Infect Dis 2021;7:518-34. [PMID: 33590753 DOI: 10.1021/acsinfecdis.0c00724] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 11.0] [Reference Citation Analysis]
27 Dos Santos AL, Amaral M, Hasegawa FR, Lago JHG, Tempone AG, Sartorelli P. (-)-T-Cadinol-a Sesquiterpene Isolated From Casearia sylvestris (Salicaceae)-Displayed In Vitro Activity and Causes Hyperpolarization of the Membrane Potential of Trypanosoma cruzi. Front Pharmacol 2021;12:734127. [PMID: 34803682 DOI: 10.3389/fphar.2021.734127] [Reference Citation Analysis]
28 Cotuá J, Llinás H, Cotes S, Chiessi E. Virtual Screening Based on QSAR and Molecular Docking of Possible Inhibitors Targeting Chagas CYP51. Journal of Chemistry 2021;2021:1-15. [DOI: 10.1155/2021/6640624] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
29 Alonso L, de Paula JC, Baréa P, Sarragiotto MH, Ueda-Nakamura T, Alonso A, de Souza Fernandes N, Lancheros CAC, Volpato H, Lazarin-Bidóia D, Nakamura CV. Membrane dynamics in Leishmania amazonensis and antileishmanial activities of β-carboline derivatives. Biochim Biophys Acta Biomembr 2021;1863:183473. [PMID: 32937102 DOI: 10.1016/j.bbamem.2020.183473] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
30 Mtemeli FL, Ndlovu J, Mugumbate G, Makwikwi T, Shoko R. Advances in schistosomiasis drug discovery based on natural products. All Life 2022;15:608-22. [DOI: 10.1080/26895293.2022.2080281] [Reference Citation Analysis]
31 Van Bocxlaer K, Croft SL. Pharmacokinetics and pharmacodynamics in the treatment of cutaneous leishmaniasis - challenges and opportunities. RSC Med Chem 2021;12:472-82. [PMID: 34041488 DOI: 10.1039/d0md00343c] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Yang C, Tan Y, Qi H, Zhou J, Long L, Zhan Q, Wang Y, Yuan X, Kang C. Boosting of the enhanced permeability and retention effect with nanocapsules improves the therapeutic effects of cetuximab. Cancer Biol Med 2020;17:433-43. [PMID: 32587779 DOI: 10.20892/j.issn.2095-3941.2019.0292] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
33 Rivas F, Medeiros A, Quiroga C, Benítez D, Comini M, Rodríguez-Arce E, Machado I, Cerecetto H, Gambino D. New Pd-Fe ferrocenyl antiparasitic compounds with bioactive 8-hydroxyquinoline ligands: a comparative study with their Pt-Fe analogues. Dalton Trans 2021;50:1651-65. [PMID: 33449983 DOI: 10.1039/d0dt03963b] [Reference Citation Analysis]
34 Sear CE, Pieper P, Amaral M, Romanelli MM, Costa-Silva TA, Haugland MM, Tate JA, Lago JHG, Tempone AG, Anderson EA. Synthesis and Structure-Activity Relationship of Dehydrodieugenol B Neolignans against Trypanosoma cruzi. ACS Infect Dis 2020;6:2872-8. [PMID: 33047947 DOI: 10.1021/acsinfecdis.0c00523] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
35 Bouton J, Maes L, Karalic I, Caljon G, Van Calenbergh S. Synthesis and evaluation of a collection of purine-like C-nucleosides as antikinetoplastid agents. Eur J Med Chem 2021;212:113101. [PMID: 33385837 DOI: 10.1016/j.ejmech.2020.113101] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
36 Wang L, Yin Q, Liu C, Tang Y, Sun C, Zhuang J. Nanoformulations of Ursolic Acid: A Modern Natural Anticancer Molecule. Front Pharmacol 2021;12:706121. [PMID: 34295253 DOI: 10.3389/fphar.2021.706121] [Reference Citation Analysis]
37 Lin C, Karalic I, Matheeussen A, Feijens P, Hulpia F, Maes L, Caljon G, Van Calenbergh S. Exploration of 6-methyl-7-(Hetero)Aryl-7-Deazapurine ribonucleosides as antileishmanial agents. European Journal of Medicinal Chemistry 2022. [DOI: 10.1016/j.ejmech.2022.114367] [Reference Citation Analysis]
38 Tempone AG, Pieper P, Borborema SET, Thevenard F, Lago JHG, Croft SL, Anderson EA. Marine alkaloids as bioactive agents against protozoal neglected tropical diseases and malaria. Nat Prod Rep 2021;38:2214-35. [PMID: 34913053 DOI: 10.1039/d0np00078g] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
39 Foscolos AS, Tsotinis A, Taylor MC, Kelly JM, Papanastasiou IP. Probing Adamantane Arylhydroxamic Acids against Trypanosoma brucei and Trypanosoma cruzi. Molbank 2022;2022:M1363. [DOI: 10.3390/m1363] [Reference Citation Analysis]
40 Viana Nunes AM, das Chagas Pereira de Andrade F, Filgueiras LA, de Carvalho Maia OA, Cunha RLOR, Rodezno SVA, Maia Filho ALM, de Amorim Carvalho FA, Braz DC, Mendes AN. preADMET analysis and clinical aspects of dogs treated with the Organotellurium compound RF07: A possible control for canine visceral leishmaniasis? Environ Toxicol Pharmacol 2020;80:103470. [PMID: 32814174 DOI: 10.1016/j.etap.2020.103470] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
41 Kober AKMH, Riaz Rajoka MS, Mehwish HM, Villena J, Kitazawa H. Immunomodulation Potential of Probiotics: A Novel Strategy for Improving Livestock Health, Immunity, and Productivity. Microorganisms 2022;10:388. [DOI: 10.3390/microorganisms10020388] [Reference Citation Analysis]
42 Harrison JR, Sarkar S, Hampton S, Riley J, Stojanovski L, Sahlberg C, Appelqvist P, Erath J, Mathan V, Rodriguez A, Kaiser M, Pacanowska DG, Read KD, Johansson NG, Gilbert IH. Discovery and Optimization of a Compound Series Active against Trypanosoma cruzi, the Causative Agent of Chagas Disease. J Med Chem 2020;63:3066-89. [PMID: 32134269 DOI: 10.1021/acs.jmedchem.9b01852] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Yu Y, Li Z, Guo R, Qian J, Zhang H, Zhang J, Zhao X, Wang S, Wang Y. Ononin, sec-O-β-d-glucosylhamaudol and astragaloside I: antiviral lead compounds identified via high throughput screening and biological validation from traditional Chinese medicine Zhongjing formulary. Pharmacological Research 2019;145:104248. [DOI: 10.1016/j.phrs.2019.04.032] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
44 Degotte G, Pirotte B, Frédérich M, Francotte P. Polyhydroxybenzoic acid derivatives as potential new antimalarial agents. Arch Pharm (Weinheim) 2021;:e2100190. [PMID: 34346088 DOI: 10.1002/ardp.202100190] [Reference Citation Analysis]
45 Saccoliti F, Di Santo R, Costi R. Recent Advancement in the Search of Innovative Antiprotozoal Agents Targeting Trypanothione Metabolism. ChemMedChem 2020;15:2420-35. [PMID: 32805075 DOI: 10.1002/cmdc.202000325] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
46 He T, Li J, Liu L, Ge S, Yan M, Liu H, Yu J. Origami-based “Book” shaped three-dimensional electrochemical paper microdevice for sample-to-answer detection of pathogens. RSC Adv 2020;10:25808-16. [DOI: 10.1039/d0ra03833d] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
47 Banerjee H, Knoblach B, Rachubinski RA. The early-acting glycosome biogenic protein Pex3 is essential for trypanosome viability. Life Sci Alliance 2019;2:e201900421. [PMID: 31341002 DOI: 10.26508/lsa.201900421] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
48 Pauli I, Rezende CO Jr, Slafer BW, Dessoy MA, de Souza ML, Ferreira LLG, Adjanohun ALM, Ferreira RS, Magalhães LG, Krogh R, Michelan-Duarte S, Del Pintor RV, da Silva FBR, Cruz FC, Dias LC, Andricopulo AD. Multiparameter Optimization of Trypanocidal Cruzain Inhibitors With In Vivo Activity and Favorable Pharmacokinetics. Front Pharmacol 2021;12:774069. [PMID: 35069198 DOI: 10.3389/fphar.2021.774069] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Daley SK, Cordell GA. Biologically Significant and Recently Isolated Alkaloids from Endophytic Fungi. J Nat Prod 2021;84:871-97. [PMID: 33534564 DOI: 10.1021/acs.jnatprod.0c01195] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
50 Forte B, Ottilie S, Plater A, Campo B, Dechering KJ, Gamo FJ, Goldberg DE, Istvan ES, Lee M, Lukens AK, McNamara CW, Niles JC, Okombo J, Pasaje CFA, Siegel MG, Wirth D, Wyllie S, Fidock DA, Baragaña B, Winzeler EA, Gilbert IH. Prioritization of Molecular Targets for Antimalarial Drug Discovery. ACS Infect Dis 2021;7:2764-76. [PMID: 34523908 DOI: 10.1021/acsinfecdis.1c00322] [Reference Citation Analysis]
51 Tibúrcio M, Yang ASP, Yahata K, Suárez-Cortés P, Belda H, Baumgarten S, van de Vegte-Bolmer M, van Gemert GJ, van Waardenburg Y, Levashina EA, Sauerwein RW, Treeck M. A Novel Tool for the Generation of Conditional Knockouts To Study Gene Function across the Plasmodium falciparum Life Cycle. mBio 2019;10:e01170-19. [PMID: 31530668 DOI: 10.1128/mBio.01170-19] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 5.3] [Reference Citation Analysis]
52 Osorio-Méndez JF, Cevallos AM. Discovery and Genetic Validation of Chemotherapeutic Targets for Chagas' Disease. Front Cell Infect Microbiol 2018;8:439. [PMID: 30666299 DOI: 10.3389/fcimb.2018.00439] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
53 Nguyen VH, Tichý M, Rožánková S, Pohl R, Downey AM, Doleželová E, Tloušťová E, Slapničková M, Zíková A, Hocek M. Synthesis and anti-trypanosomal activity of 3'-fluororibonucleosides derived from 7-deazapurine nucleosides. Bioorg Med Chem Lett 2021;40:127957. [PMID: 33741462 DOI: 10.1016/j.bmcl.2021.127957] [Reference Citation Analysis]
54 Kobakhidze G, Sethi A, Valimehr S, Ralph SA, Rouiller I. The AAA+ ATPase p97 as a novel parasite and tuberculosis drug target. Trends in Parasitology 2022. [DOI: 10.1016/j.pt.2022.03.004] [Reference Citation Analysis]
55 Fernandes VS, da Rosa R, Zimmermann LA, Rogério KR, Kümmerle AE, Bernardes LSC, Graebin CS. Antiprotozoal agents: How have they changed over a decade? Arch Pharm (Weinheim) 2021;:e2100338. [PMID: 34661935 DOI: 10.1002/ardp.202100338] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
56 Lin C, Ferreira de Almeida Fiuza L, Cardoso Santos C, Ferreira Nunes D, Cruz Moreira O, Bouton J, Karalic I, Maes L, Caljon G, Hulpia F, de Nazaré C Soeiro M, Van Calenbergh S. 6-Methyl-7-Aryl-7-Deazapurine Nucleosides as Anti-Trypanosoma cruzi Agents: Structure-Activity Relationship and in vivo Efficacy. ChemMedChem 2021;16:2231-53. [PMID: 33856742 DOI: 10.1002/cmdc.202100144] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
57 Brown RW, Abdel-Megeed AM, Keller PA, Jones AJ, Sykes ML, Kaiser M, Baell JB, Avery VM, Hyland CJT. Investigation of thiazolyl-benzothiophenamides as potential agents for African sleeping sickness. RSC Med Chem 2020;11:1413-22. [PMID: 34095848 DOI: 10.1039/d0md00277a] [Reference Citation Analysis]
58 Camargo de Lima J, Floriani MA, Debarba JA, Paludo GP, Monteiro KM, Moura H, Barr JR, Zaha A, Ferreira HB. Dynamics of protein synthesis in the initial steps of strobilation in the model cestode parasite Mesocestoides corti (syn. vogae). J Proteomics 2020;228:103939. [PMID: 32798775 DOI: 10.1016/j.jprot.2020.103939] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
59 De Rycker M, Horn D, Aldridge B, Amewu RK, Barry CE 3rd, Buckner FS, Cook S, Ferguson MAJ, Gobeau N, Herrmann J, Herrling P, Hope W, Keiser J, Lafuente-Monasterio MJ, Leeson PD, Leroy D, Manjunatha UH, McCarthy J, Miles TJ, Mizrahi V, Moshynets O, Niles J, Overington JP, Pottage J, Rao SPS, Read KD, Ribeiro I, Silver LL, Southern J, Spangenberg T, Sundar S, Taylor C, Van Voorhis W, White NJ, Wyllie S, Wyatt PG, Gilbert IH. Setting Our Sights on Infectious Diseases. ACS Infect Dis 2020;6:3-13. [PMID: 31808676 DOI: 10.1021/acsinfecdis.9b00371] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
60 Banerjee H, LaPointe P, Eitzen G, Rachubinski RA. A Small Molecule Inhibitor of Pex3-Pex19 Interaction Disrupts Glycosome Biogenesis and Causes Lethality in Trypanosoma brucei. Front Cell Dev Biol 2021;9:703603. [PMID: 34350186 DOI: 10.3389/fcell.2021.703603] [Reference Citation Analysis]
61 Bellini V, Swale C, Brenier-Pinchart MP, Pezier T, Georgeault S, Laurent F, Hakimi MA, Bougdour A. Target Identification of an Antimalarial Oxaborole Identifies AN13762 as an Alternative Chemotype for Targeting CPSF3 in Apicomplexan Parasites. iScience 2020;23:101871. [PMID: 33336164 DOI: 10.1016/j.isci.2020.101871] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
62 Torrie LS, Robinson DA, Thomas MG, Hobrath JV, Shepherd SM, Post JM, Ko EJ, Ferreira RA, Mackenzie CJ, Wrobel K, Edwards DP, Gilbert IH, Gray DW, Fairlamb AH, De Rycker M. Discovery of an Allosteric Binding Site in Kinetoplastid Methionyl-tRNA Synthetase. ACS Infect Dis 2020;6:1044-57. [PMID: 32275825 DOI: 10.1021/acsinfecdis.9b00453] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
63 Van den Kerkhof M, Sterckx YG, Leprohon P, Maes L, Caljon G. Experimental Strategies to Explore Drug Action and Resistance in Kinetoplastid Parasites. Microorganisms 2020;8:E950. [PMID: 32599761 DOI: 10.3390/microorganisms8060950] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
64 Mercaldi GF, Eufrásio AG, Ranzani AT, do Nascimento Faria J, Mota SGR, Fagundes M, Bruder M, Cordeiro AT. Trypanosoma cruzi Malic Enzyme Is the Target for Sulfonamide Hits from the GSK Chagas Box. ACS Infect Dis 2021;7:2455-71. [PMID: 34279922 DOI: 10.1021/acsinfecdis.1c00231] [Reference Citation Analysis]
65 Perlíková P, Krajczyk A, Doleželová E, Slapničková M, Milisavljevic N, Slavětínská LP, Tloušt'ová E, Gurská S, Džubák P, Hajdúch M, Zíková A, Hocek M. Synthesis and Antitrypanosomal Activity of 6-Substituted 7-Methyl-7-deazapurine Nucleosides. ACS Infect Dis 2021;7:917-26. [PMID: 33769794 DOI: 10.1021/acsinfecdis.1c00062] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
66 Bahuguna A, Rawat DS. An overview of new antitubercular drugs, drug candidates, and their targets. Med Res Rev 2020;40:263-92. [PMID: 31254295 DOI: 10.1002/med.21602] [Cited by in Crossref: 39] [Cited by in F6Publishing: 30] [Article Influence: 13.0] [Reference Citation Analysis]
67 Bernal FA, Schmidt TJ. A Comprehensive QSAR Study on Antileishmanial and Antitrypanosomal Cinnamate Ester Analogues. Molecules 2019;24:E4358. [PMID: 31795283 DOI: 10.3390/molecules24234358] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
68 Clare RH, Hall SR, Patel RN, Casewell NR. Small Molecule Drug Discovery for Neglected Tropical Snakebite. Trends in Pharmacological Sciences 2021;42:340-53. [DOI: 10.1016/j.tips.2021.02.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
69 Rahman A, O'Sullivan P, Rozas I. Recent developments in compounds acting in the DNA minor groove. Medchemcomm 2019;10:26-40. [PMID: 30774852 DOI: 10.1039/c8md00425k] [Cited by in Crossref: 20] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
70 Xie YP, Sangaraiah N, Meng JP, Zhou CH. Unique Carbazole-Oxadiazole Derivatives as New Potential Antibiotics for Combating Gram-Positive and -Negative Bacteria. J Med Chem 2022. [PMID: 35389643 DOI: 10.1021/acs.jmedchem.2c00001] [Reference Citation Analysis]
71 Kwofie SK, Broni E, Dankwa B, Enninful KS, Kwarko GB, Darko L, Durvasula R, Kempaiah P, Rathi B, Miller Iii WA, Yaya A, Wilson MD. Outwitting an Old Neglected Nemesis: A Review on Leveraging Integrated Data-Driven Approaches to Aid in Unraveling of Leishmanicides of Therapeutic Potential. Curr Top Med Chem 2020;20:349-66. [PMID: 31994465 DOI: 10.2174/1568026620666200128160454] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
72 Kannigadu C, N'Da DD. Recent Advances in the Synthesis and Development of Nitroaromatics as Anti-Infective Drugs. Curr Pharm Des 2020;26:4658-74. [PMID: 32228417 DOI: 10.2174/1381612826666200331091853] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
73 Shrivastav MT, Malik Z, Somlata. Revisiting Drug Development Against the Neglected Tropical Disease, Amebiasis. Front Cell Infect Microbiol 2020;10:628257. [PMID: 33718258 DOI: 10.3389/fcimb.2020.628257] [Reference Citation Analysis]
74 de Souza AS, Ferreira LLG, de Oliveira AS, Andricopulo AD. Quantitative Structure-Activity Relationships for Structurally Diverse Chemotypes Having Anti-Trypanosoma cruzi Activity. Int J Mol Sci 2019;20:E2801. [PMID: 31181717 DOI: 10.3390/ijms20112801] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
75 Clemente CM, Pineda T, Yepes LM, Upegui Y, Allemandi DA, Robledo SM, Ravetti S. Eugenol carbonate activity against Plasmodium falciparum, Leishmania braziliensis, and Trypanosoma cruzi. Arch Pharm (Weinheim) 2021;:e2100432. [PMID: 34954824 DOI: 10.1002/ardp.202100432] [Reference Citation Analysis]
76 Bouton J, Ferreira de Almeida Fiuza L, Cardoso Santos C, Mazzarella MA, Soeiro MNC, Maes L, Karalic I, Caljon G, Van Calenbergh S. Revisiting Pyrazolo[3,4-d]pyrimidine Nucleosides as Anti-Trypanosoma cruzi and Antileishmanial Agents. J Med Chem 2021;64:4206-38. [PMID: 33784107 DOI: 10.1021/acs.jmedchem.1c00135] [Reference Citation Analysis]
77 Baragaña B, Forte B, Choi R, Nakazawa Hewitt S, Bueren-Calabuig JA, Pisco JP, Peet C, Dranow DM, Robinson DA, Jansen C, Norcross NR, Vinayak S, Anderson M, Brooks CF, Cooper CA, Damerow S, Delves M, Dowers K, Duffy J, Edwards TE, Hallyburton I, Horst BG, Hulverson MA, Ferguson L, Jiménez-Díaz MB, Jumani RS, Lorimer DD, Love MS, Maher S, Matthews H, McNamara CW, Miller P, O'Neill S, Ojo KK, Osuna-Cabello M, Pinto E, Post J, Riley J, Rottmann M, Sanz LM, Scullion P, Sharma A, Shepherd SM, Shishikura Y, Simeons FRC, Stebbins EE, Stojanovski L, Straschil U, Tamaki FK, Tamjar J, Torrie LS, Vantaux A, Witkowski B, Wittlin S, Yogavel M, Zuccotto F, Angulo-Barturen I, Sinden R, Baum J, Gamo FJ, Mäser P, Kyle DE, Winzeler EA, Myler PJ, Wyatt PG, Floyd D, Matthews D, Sharma A, Striepen B, Huston CD, Gray DW, Fairlamb AH, Pisliakov AV, Walpole C, Read KD, Van Voorhis WC, Gilbert IH. Lysyl-tRNA synthetase as a drug target in malaria and cryptosporidiosis. Proc Natl Acad Sci U S A 2019;116:7015-20. [PMID: 30894487 DOI: 10.1073/pnas.1814685116] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 13.7] [Reference Citation Analysis]
78 Revuelto A, López-Martín I, de Lucio H, García-Soriano JC, Zanda N, de Castro S, Gago F, Jiménez-Ruiz A, Velázquez S, Camarasa MJ. Small Molecule-Peptide Conjugates as Dimerization Inhibitors of Leishmania infantum Trypanothione Disulfide Reductase. Pharmaceuticals (Basel) 2021;14:689. [PMID: 34358115 DOI: 10.3390/ph14070689] [Reference Citation Analysis]
79 de Godoy AS, Sachetto Fernandes R, Campos Aguiar AC, Vieira Bueno R, de Moraes Roso Mesquita NC, Carvalho Guido RV, Oliva G. Structural and mechanistic insight from antiviral and antiparasitic enzyme drug targets for tropical infectious diseases. Curr Opin Struct Biol 2019;59:65-72. [PMID: 30954758 DOI: 10.1016/j.sbi.2019.02.014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
80 González M, Alcolea PJ, Álvarez R, Medarde M, Larraga V, Peláez R. New diarylsulfonamide inhibitors of Leishmania infantum amastigotes. Int J Parasitol Drugs Drug Resist 2021;16:45-64. [PMID: 34015753 DOI: 10.1016/j.ijpddr.2021.02.006] [Reference Citation Analysis]